Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ceribell (CBLL) EBT (2023 - 2025)

Historic EBT for Ceribell (CBLL) over the last 3 years, with Q3 2025 value amounting to -$13.5 million.

  • Ceribell's EBT fell 2925.99% to -$13.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$52.5 million, marking a year-over-year decrease of 4510.83%. This contributed to the annual value of -$40.5 million for FY2024, which is 3735.44% down from last year.
  • Ceribell's EBT amounted to -$13.5 million in Q3 2025, which was down 2925.99% from -$13.6 million recorded in Q2 2025.
  • Over the past 5 years, Ceribell's EBT peaked at -$7.1 million during Q3 2023, and registered a low of -$13.6 million during Q2 2025.
  • Moreover, its 3-year median value for EBT was -$10.4 million (2024), whereas its average is -$10.6 million.
  • Over the last 5 years, Ceribell's EBT had its largest YoY gain of 2925.99% in 2025, and its largest YoY loss of 5258.92% in 2025.
  • Quarter analysis of 3 years shows Ceribell's EBT stood at -$8.3 million in 2023, then tumbled by 51.99% to -$12.6 million in 2024, then dropped by 7.07% to -$13.5 million in 2025.
  • Its EBT stands at -$13.5 million for Q3 2025, versus -$13.6 million for Q2 2025 and -$12.8 million for Q1 2025.